This study suggests that blocking Notch1 − Hes1 signaling in HNSCC might be an effective way to reduce immunosuppression and enhance therapeutic efficacy [19] (Table 2). This evidence concerns the gene NOTCH1 and head and neck squamous cell carcinoma.